Clinical Trial Update: Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer

View source ↗

Summary

A clinical trial evaluating molecular diagnosis using circulating tumor DNA in non-small cell lung cancer (stages IIIb and IV) has completed. The study was spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Rennes University Hospital | Conditions: Stage IIIb and IV Non Small Cell Lung Cancer | Status: COMPLETED